StocksFundsScreenerSectorsWatchlists
CERT

CERT - Certara, Inc. Stock Price, Fair Value and News

17.66USD-0.78 (-4.23%)Market Closed

Market Summary

CERT
USD17.66-0.78
Market Closed
-4.23%

CERT Alerts

  • 1 major insider sales recently.

CERT Stock Price

View Fullscreen

CERT RSI Chart

CERT Valuation

Market Cap

2.8B

Price/Earnings (Trailing)

-51

Price/Sales (Trailing)

7.97

EV/EBITDA

-93.77

Price/Free Cashflow

34.86

CERT Price/Sales (Trailing)

CERT Profitability

Operating Margin

60.20%

EBT Margin

-15.56%

Return on Equity

-5.29%

Return on Assets

-3.54%

Free Cashflow Yield

2.87%

CERT Fundamentals

CERT Revenue

Revenue (TTM)

354.3M

Rev. Growth (Yr)

1.59%

Rev. Growth (Qtr)

2.84%

CERT Earnings

Earnings (TTM)

-55.4M

Earnings Growth (Yr)

-235.78%

Earnings Growth (Qtr)

74.56%

Breaking Down CERT Revenue

Last 7 days

-2.7%

Last 30 days

-7.8%

Last 90 days

8.1%

Trailing 12 Months

-25.7%

How does CERT drawdown profile look like?

CERT Financial Health

Current Ratio

2.62

Debt/Equity

0.28

Debt/Cashflow

0.29

CERT Investor Care

Shares Dilution (1Y)

0.11%

Diluted EPS (TTM)

-0.35

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
2023344.4M352.1M353.0M354.3M
2022300.9M313.6M324.4M335.6M
2021252.8M261.8M275.4M286.1M
2020217.3M226.0M234.8M243.5M
2019000208.5M

Tracking the Latest Insider Buys and Sells of Certara, Inc.

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
Apr 02, 2024
smith patrick f
sold
-243,161
16.8546
-14,427
president, drug dev solutions
Apr 01, 2024
feehery william f
sold (taxes)
-762,206
17.88
-42,629
chief executive officer
Apr 01, 2024
feehery william f
acquired
-
-
69,799
chief executive officer
Apr 01, 2024
aspbury robert
acquired
-
-
16,498
president; scientific software
Apr 01, 2024
gallagher john e
sold (taxes)
-162,297
17.88
-9,077
chief financial officer
Apr 01, 2024
traynor richard m.
acquired
-
-
13,295
svp and general counsel
Apr 01, 2024
sherman nicolette d
sold (taxes)
-46,094
17.88
-2,578
chief human resources officer
Apr 01, 2024
pedersen leif e
sold (taxes)
-106,404
17.88
-5,951
president, chief commercal off
Apr 01, 2024
smith patrick f
sold (taxes)
-124,355
17.88
-6,955
president, drug dev solutions
Apr 01, 2024
aspbury robert
sold (taxes)
-189,975
17.88
-10,625
president; scientific software

1–10 of 50

Which funds bought or sold CERT recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Apr 10, 2024
Yarbrough Capital, LLC
sold off
-100
-227,861
-
-%
Apr 10, 2024
Banque Cantonale Vaudoise
sold off
-100
-177,000
-
-%
Apr 09, 2024
MATHER GROUP, LLC.
new
-
13,685
13,685
-%
Apr 09, 2024
MASSMUTUAL TRUST CO FSB/ADV
unchanged
-
24.00
1,502
-%
Apr 05, 2024
FIRST HAWAIIAN BANK
new
-
618,308
618,308
0.02%
Apr 05, 2024
GAMMA Investing LLC
added
38.62
3,752
10,782
-%
Apr 05, 2024
CWM, LLC
reduced
-9.57
-1,000
10,000
-%
Apr 03, 2024
Versant Capital Management, Inc
unchanged
-
74.00
4,524
-%
Mar 22, 2024
PNC FINANCIAL SERVICES GROUP, INC.
reduced
-39.4
-41,414
113,756
-%
Mar 11, 2024
VANGUARD GROUP INC
reduced
-0.15
37,988,800
220,659,000
-%

1–10 of 49

Are Funds Buying or Selling CERT?

Are funds buying CERT calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own CERT
No. of Funds

Unveiling Certara, Inc.'s Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 13, 2024
vanguard group inc
7.85%
12,544,560
SC 13G/A
Jan 30, 2024
baillie gifford & co
5.58%
8,921,463
SC 13G/A
Jan 25, 2024
blackrock inc.
8.7%
13,956,611
SC 13G
Feb 09, 2023
vanguard group inc
6.80%
10,850,994
SC 13G/A
Feb 09, 2023
eqt avatar parent l.p.
0%
0
SC 13G/A
Jan 18, 2023
baillie gifford & co
6.40%
10,223,809
SC 13G/A
Dec 16, 2022
arsenal capital partners iii lp
2.2%
3,559,745
SC 13D
Feb 14, 2022
eqt avatar parent l.p.
23.5%
37,458,939
SC 13G/A
Feb 09, 2022
vanguard group inc
5.92%
9,310,068
SC 13G

Recent SEC filings of Certara, Inc.

View All Filings
Date Filed Form Type Document
Apr 12, 2024
DEFA14A
DEFA14A
Apr 10, 2024
ARS
ARS
Apr 10, 2024
DEF 14A
DEF 14A
Apr 10, 2024
DEFA14A
DEFA14A
Apr 05, 2024
4/A
Insider Trading
Apr 04, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading
Apr 03, 2024
4
Insider Trading

Peers (Alternatives to Certara, Inc.)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
404.6B
371.6B
-10.06% -16.60%
18.08
1.09
14.64% 11.24%
102.3B
195.3B
0.36% 32.66%
19.05
0.52
8.17% -20.79%
86.4B
357.8B
-8.56% -8.98%
10.34
0.24
10.95% 93.52%
85.4B
65.0B
0.28% 18.07%
16.29
1.31
7.86% -7.11%
37.8B
154.0B
-7.79% 1.99%
14
0.25
6.54% 124.79%
11.6B
14.3B
-4.37% 22.44%
16.11
0.81
6.59% 6.24%
11.4B
12.1B
-5.66% 54.55%
16.54
0.94
4.57% 23.40%
MID-CAP
9.4B
2.3B
-4.31% 9.94%
34.32
4.13
6.06% 9.17%
6.8B
2.9B
-6.65% -2.97%
-311.58
2.31
12.20% -107.93%
2.3B
1.4B
-0.51% 1.54%
37.23
1.63
21.19% 34.42%
2.1B
3.8B
-4.61% -35.19%
10.19
0.57
-27.73% -52.50%
SMALL-CAP
1.6B
1.1B
-1.23% -12.42%
25.41
1.5
11.31% 35.83%
1.2B
3.0B
4.69% 55.53%
-6.48
0.41
6.74% 20.73%
51.1M
-
-15.28% -9.77%
-3.49
-
- -12.94%
18.5M
21.3M
10.98% 5.02%
34.8
0.87
8.00% -62.25%

Certara, Inc. News

Latest updates
Simply Wall St11 Apr 202412:56 pm
Defense World11 Apr 202408:45 am
MarketBeat02 Apr 202408:26 am
InvestorsObserver28 Mar 202407:00 am
Simply Wall St21 Mar 202407:00 am
Seeking Alpha29 Feb 202408:00 am
Yahoo Finance21 Feb 202408:00 am

Certara, Inc. Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Thousands)
Income Statement (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Revenue2.8%88.0086.0090.0090.0087.0085.0083.0082.0075.0074.0070.0067.0065.0060.0061.0057.00-
Cost Of Revenue-5.0%34.0036.0036.0035.0032.0033.0035.0033.0029.0029.0028.0026.0035.0023.0021.0022.00-
Operating Expenses-39.1%62.0010241.0048.0043.0041.0043.0043.0043.0046.0037.0035.0083.0030.0027.0027.00-
  S&GA Expenses19.8%9.007.008.008.008.006.007.006.007.005.005.004.0010.003.003.003.00-
  R&D Expenses-10.7%8.009.008.009.007.006.008.008.007.005.005.005.0011.003.003.003.00-
EBITDA Margin-103.8%-0.09*-0.04*0.13*0.11*0.11*0.10*0.06*0.06*0.05*-0.15*-0.13*------
Interest Expenses-0.6%6.006.006.005.005.005.004.003.003.003.006.004.005.006.007.007.00-
Income Taxes101.6%0.00-4.644.001.00-5.455.003.002.0010.00-1.631.001.00-5.480.004.001.00-
Earnings Before Taxes76.9%-12.38-53.618.002.004.008.003.004.00-0.16-3.39-1.402.00-59.932.007.002.00-
EBT Margin-40.7%-0.16*-0.11*0.07*0.05*0.06*0.05*0.01*0.00*-0.01*-0.23*-0.22*------
Net Income74.6%-12.46-48.965.001.009.004.00-0.592.00-9.70-1.76-2.861.00-54.451.003.001.00-
Net Income Margin-63.5%-0.16*-0.10*0.05*0.04*0.04*-0.01*-0.03*-0.04*-0.05*-0.21*-0.21*------
Free Cashflow-27.8%22.0031.0018.0010.0035.0024.0023.009.0021.0020.0014.00------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q4
Assets2.4%1,5631,5271,5721,5671,5731,5091,5021,5071,5121,4151,2651,2631,269
  Current Assets-8.0%340370353348342305286275275505345348347
    Cash Equivalents-13.7%235272245244237214198185187418270273273
  Net PPE25.6%3.002.002.002.002.003.003.003.003.003.003.004.004.00
  Goodwill2758.2%71625.002.00719718697701705703181524519519
Liabilities8.7%516475475482493454453459470443431435447
  Current Liabilities23.3%13010510394.0010377.0082.0082.0092.0070.0059.0063.0075.00
  Long Term Debt-0.2%288289289290290290291291292292293294294
    LT Debt, Current0%3.003.003.003.003.003.003.003.003.003.003.005.005.00
    LT Debt, Non Current-0.2%288289289290290290291291292292293294294
Shareholder's Equity-0.5%1,0471,0521,0971,0851,0801,0541,0481,0481,042971835827822
  Retained Earnings-12.0%-116-103-54.81-59.51-60.87-70.05-73.98-73.39-75.60-65.90-64.14-61.29-62.34
  Additional Paid-In Capital0.6%1,1781,1711,1621,1591,1501,1441,1371,1271,1201,039897890885
Shares Outstanding0.0%160160160160160157156156150149147--
Float---2,200---2,500---2,100--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q4
Cashflow From Operations-25.7%23,32631,41418,0589,95735,48523,99623,2599,80320,83120,00114,6224,93412,68115,4887,8188,823-
Cashflow From Investing-1410.7%-61,047-4,041-11,731-2,731-12,599-3,324-3,238-8,676-249,323-2,600-14,541-3,458-1,403-1,968-2,232-3,009-
Cashflow From Financing-35.4%-1,252-925-6,420-850-968-1,344-3,531-1,520-3,644132,200-4,310-855232,317-41,289-1,84519,031-
  Buy Backs--------------1,024---

CERT Income Statement

2023-12-31
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Income Statement [Abstract]   
Revenues$ 354,337$ 335,644$ 286,104
Cost of revenues141,022132,577111,616
Operating expenses:   
Sales and marketing32,02227,40820,141
Research and development34,17328,20520,379
General and administrative95,38571,77379,539
Intangible asset amortization43,97341,42938,715
Depreciation and amortization expense1,5521,7312,135
Goodwill impairment expense46,98400
Total operating expenses254,089170,546160,909
Income (loss) from operations(40,774)32,52113,579
Other expenses:   
Interest expense(22,916)(17,773)(16,837)
Net other income (expense)8,5474,007(117)
Total other expenses(14,369)(13,766)(16,954)
Income (loss) before income taxes(55,143)18,755(3,375)
Provision for income taxes2144,0249,891
Net income (loss)(55,357)14,731(13,266)
Other comprehensive income (loss)   
Foreign currency translation adjustment, net of tax of $(717), $(916), $1952,696(10,490)(5,154)
Change in fair value of interest rate swap, net of tax of $1,393, 2,056, $(16)(2,059)6,186547
Reclassification of fair value of interest rate swap, net of tax of $0, $0, $(765)002,268
Total other comprehensive income (loss)637(4,304)(2,339)
Comprehensive income (loss)$ (54,720)$ 10,427$ (15,605)
Net income (loss) per share attributable to common stockholders:   
Basic (in dollars per share)$ (0.35)$ 0.09$ (0.09)
Diluted (in dollars per share)$ (0.35)$ 0.09$ (0.09)
Weighted average common shares outstanding:   
Basic (in shares)158,936,251156,876,942149,842,668
Diluted (in shares)158,936,251159,354,394149,842,668

CERT Balance Sheet

2023-12-31
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Dec. 31, 2023
Dec. 31, 2022
Current assets:  
Cash and cash equivalents$ 234,951$ 236,586
Accounts receivable, net of allowances for credit losses of $1,312 and $1,250, respectively84,85782,584
Restricted cash03,102
Prepaid expenses and other current assets20,39319,980
Total current assets340,201342,252
Other assets:  
Property and equipment, net2,6702,400
Operating lease right-of-use assets9,60414,427
Goodwill716,333717,743
Intangible assets, net of $273,522 and $217,705, respectively487,043486,782
Deferred income taxes4,2363,703
Other long-term assets3,0535,615
Total assets1,563,1401,572,922
Current liabilities:  
Accounts payable5,1717,533
Accrued expenses56,77935,403
Current portion of deferred revenue60,67852,209
Current portion of long-term debt3,0203,020
Other current liabilities4,3754,993
Total current liabilities130,023103,158
Long-term liabilities:  
Deferred revenue, net of current portion1,0702,815
Deferred income taxes50,82665,046
Operating lease liabilities, net of current portion6,95510,133
Long-term debt, net of current portion and debt discount288,217289,988
Other long-term liabilities39,20922,121
Total liabilities516,300493,261
Commitments and contingencies
Stockholders' equity  
Preferred shares, $0.01 par value, 50,000,000 and no shares authorized, issued, and outstanding as of December 31, 2023 and 2022, respectively00
Common shares, $0.01 par value, 600,000,000 shares authorized, 160,284,901 and 159,676,150 shares issued as of December 31, 2023 and 2022, respectively; 159,848,286 and 159,525,943 shares outstanding as of December 31, 2023 and 2022, respectively1,6031,596
Additional paid-in capital1,178,4611,150,168
Accumulated deficit(116,230)(60,873)
Accumulated other comprehensive loss(7,593)(8,230)
Treasury stock at cost, 436,615 and 150,207 shares at December 31, 2023 and 2022, respectively(9,401)(3,000)
Total stockholders' equity1,046,8401,079,661
Total liabilities and stockholders' equity$ 1,563,140$ 1,572,922
Preferred share, authorized (in shares)50,000,0000
CERT
Certara, Inc., together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access. It offers medicines to patients using biosimulation software, technology, and services to transform drug discovery and development. The company also provides related technology-enabled services to guide its customers' new drugs through the regulatory submission process and into the market. Its technology-enabled services include mechanistic biosimulation, empirical biosimulation, drug development and regulatory strategy, clinical pharmacology, model-based meta-analysis, regulatory writing and medical communications, regulatory operations, and market access. Further, company offers software, comprising mechanistic biosimulation platform, empirical PK/PD biosimulation platform, data standardization and compliance software, scientific informatics platform, clinical outcomes databases for biosimulation, authoring and management of regulatory submissions platform, and market access communication platform. The company serves biopharmaceutical companies, and academic and government institutions. It has operations in the United States, Australia, Canada, China, France, Germany, India, Italy, Japan, Luxembourg, the Netherlands, the Philippines, Poland, Portugal, Spain, Switzerland, and the United Kingdom. Certara Inc. was founded in 2008 and is headquartered in Princeton, New Jersey.
 CEO
 WEBSITEcertara.com
 INDUSTRYHealthcare Plans
 EMPLOYEES1150

Certara, Inc. Frequently Asked Questions


What is the ticker symbol for Certara, Inc.? What does CERT stand for in stocks?

CERT is the stock ticker symbol of Certara, Inc.. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Certara, Inc. (CERT)?

As of Fri Apr 12 2024, market cap of Certara, Inc. is 2.82 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of CERT stock?

You can check CERT's fair value in chart for subscribers.

What is the fair value of CERT stock?

You can check CERT's fair value in chart for subscribers. The fair value of Certara, Inc. is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Certara, Inc. is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for CERT so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Certara, Inc. a good stock to buy?

The fair value guage provides a quick view whether CERT is over valued or under valued. Whether Certara, Inc. is cheap or expensive depends on the assumptions which impact Certara, Inc.'s fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for CERT.

What is Certara, Inc.'s Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 12 2024, CERT's PE ratio (Price to Earnings) is -51 and Price to Sales (PS) ratio is 7.97. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. CERT PE ratio will change depending on the future growth rate expectations of investors.